Strategies to increase nitric oxide signalling in cardiovascular disease

JO Lundberg, MT Gladwin, E Weitzberg - Nature reviews Drug …, 2015 - nature.com
Nitric oxide (NO) is a key signalling molecule in the cardiovascular, immune and central
nervous systems, and crucial steps in the regulation of NO bioavailability in health and …

The noncanonical pathway for in vivo nitric oxide generation: the nitrate-nitrite-nitric oxide pathway

V Kapil, RS Khambata, DA Jones, K Rathod… - Pharmacological …, 2020 - ASPET
In contrast to nitric oxide, which has well established and important roles in the regulation of
blood flow and thrombosis, neurotransmission, the normal functioning of the genitourinary …

cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action

SH Francis, JL Busch, JD Corbin - Pharmacological reviews, 2010 - ASPET
To date, studies suggest that biological signaling by nitric oxide (NO) is primarily mediated
by cGMP, which is synthesized by NO-activated guanylyl cyclases and broken down by …

Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a …

ES Hoendermis, LCY Liu, YM Hummel… - European heart …, 2015 - academic.oup.com
Background Heart failure with preserved ejection fraction (HFpEF), with associated
pulmonary hypertension is an increasingly large medical problem. Phosphodiesterase …

[HTML][HTML] Vascular endothelial dysfunction and pharmacological treatment

JB Su - World journal of cardiology, 2015 - ncbi.nlm.nih.gov
The endothelium exerts multiple actions involving regulation of vascular permeability and
tone, coagulation and fibrinolysis, inflammatory and immunological reactions and cell …

Clinical and molecular genetics of the phosphodiesterases (PDEs)

MF Azevedo, FR Faucz, E Bimpaki, A Horvath… - Endocrine …, 2014 - academic.oup.com
Cyclic nucleotide phosphodiesterases (PDEs) are enzymes that have the unique function of
terminating cyclic nucleotide signaling by catalyzing the hydrolysis of cAMP and GMP. They …

Role of apoptosis in reperfusion injury

F Eefting, B Rensing, J Wigman… - Cardiovascular …, 2004 - academic.oup.com
Many changes occur during reperfusion of the myocardium after ischemic damage. Necrosis
and apoptosis appear to be ongoing during ischemia, while apoptosis is boosted by the …

PDE5 inhibitors as therapeutics for heart disease, diabetes and cancer

A Das, D Durrant, FN Salloum, L Xi… - Pharmacology & …, 2015 - Elsevier
Abstract The phosphodiesterase 5 (PDE5) inhibitors, including sildenafil (Viagra™),
vardenafil (Levitra™), and tadalafil (Cialis™) have been developed for treatment of erectile …

The vital role for nitric oxide in intraocular pressure homeostasis

E Reina-Torres, ML De Ieso, LR Pasquale… - Progress in retinal and …, 2021 - Elsevier
Catalyzed by endothelial nitric oxide (NO) synthase (eNOS) activity, NO is a gaseous
signaling molecule maintaining endothelial and cardiovascular homeostasis. Principally, NO …

cAMP and cGMP signaling cross-talk: role of phosphodiesterases and implications for cardiac pathophysiology

M Zaccolo, MA Movsesian - Circulation research, 2007 - Am Heart Assoc
Cyclic nucleotide phosphodiesterases regulate cAMP-mediated signaling by controlling
intracellular cAMP content. The cAMP-hydrolyzing activity of several families of cyclic …